-
Announcing NextBillion’s Most Influential Posts of 2016
Congratulations to the three winners of NextBillion’s “Most Influential Post of 2016” contest. Each winner brought a unique mixture of topicality, engaging writing and thought-provoking analysis to their posts, which tackled some of the most important issues facing the social business world in the past year.
- Categories
- Health Care, Social Enterprise
-
What We Know – and Don’t Know – About Zika and Its Treatment
Researchers all over the world are working on a vaccine for Zika but it will probably be next year, and possibly much longer, before health officials can determine whether a vaccine works or not. Meanwhile, with pathogens and their vectors moving farther and faster than ever before, it’s just a matter of time before Zika reaches many more parts of the world.
- Categories
- Health Care
-
Weekly Roundup: A 1,030-Enterprise Survey, a Cuba/U.S. Collaboration, and a ‘Big Bet’ Primer
An expansive survey of social enterprises, a new health care collaboration between some old Cold War rivals, and an ambitious exploration of the challenges of "big bets" in philanthropy highlight this week's roundup of social business and global development news.
- Categories
- Agriculture, Education, Health Care, Social Enterprise
-
Beyond Imagination: GE, Miller Center Helping Keep Moms, Children Healthy
A pilot called healthymagination Mother and Child – a unique partnership between Santa Clara University’s Miller Center for Social Entrepreneurship, based in Silicon Valley, and GE, which is investing $20 million in the joint venture – accelerates much-needed medical innovations in nine countries across sub-Saharan Africa.
- Categories
- Health Care, Social Enterprise, Technology
-
Weekly Roundup: PSI for Profit, a Slowing ‘Pulse’ in Africa and Medical Tourism on Steroids
The non-profit Population Services International (PSI) announces the launch of a for-profit business in India, sub-Saharan Africa braces for "the lowest growth in more than 20 years," and Obamacare generates some unintended – and potentially exciting – consequences. We discuss these and other issues in our weekly roundup of social business and global development news.
- Categories
- Health Care, Investing, Social Enterprise
-
The ‘Treacherous’ Transition from a Great Tech Idea to Sustainable Business
Hyrax Biosciences recently developed Exatype, a software solution that enables health care workers to quickly and affordably determine HIV positive patients’ responsiveness to treatment. In this Q&A, Dr. Kirsten Miller-Duys, business development lead, discusses Exatype’s implications for global health, plans to turn it into a sustainable business, and Africa's emerging tech sector.
- Categories
- Health Care, Social Enterprise
-
Weekly Roundup: Dubious Controversy, Outrageous Pricing and Angels in South Africa
Among the week's highlights (and lowlights): Grameen Foundation and Muhammad Yunus make an unwelcome entrance into U.S. presidential politics, Mylan Pharmaceuticals defends itself from price-gouging accusations, and a business angel network launches in South Africa.
- Categories
- Education, Health Care, Investing, Social Enterprise
-
Creating ‘Solavores’ By Thinking Inside the Box
Solavore, launched last year, sells solar ovens in the developed world and uses the profits to subsidize clean-cooking technology for the 2.7 billion people in the developing world for whom wood fire is the only cooking option, with the inevitable result: lung damage.
- Categories
- Energy, Health Care, Social Enterprise
- Tags
- social enterprise, solar